Meliha Nalçacı

10PUBLICATIONS
77CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 30, 2026
Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients.

|Jun 27, 2025
CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study.

Tarık Onur Tiryaki, Aynur Dağlar Aday, Meliha Nalçacı

|Aug 08, 2024
Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy

|Dec 22, 2023
Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

Simge Erdem, Meliha Nalçacı

|Aug 16, 2023
Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

İpek Yönal-Hindilerden, Ezgi Şahin, Fehmi Hindilerden

|Sep 14, 2022
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia.

Guray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu

Pageof 2

Frequent Collaborators

4 joint publications

Aynur Dağlar-Aday

4 joint publications

İpek Yönal-Hindilerden

4 joint publications

Fehmi Hindilerden

3 joint publications

Burhan Ferhanoglu